GS expression levels in the caudate and putamen were comparable between LRRK2 G2019S PD patients and age-matched controls (Fig. 1c; LRRK2 G2019S PD patients vs controls, p = 0.37). The gene discussed is LRRK2; the disease is Parkinson disease.